Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

NCT01016730 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

AIDS-Related Kaposi Sarcoma
HIV Infection
Recurrent Kaposi Sarcoma

Interventions

DRUG: Bortezomib
OTHER: Laboratory Biomarker Analysis
OTHER: Questionnaire Administration

Sponsor

National Cancer Institute (NCI)